FGFR2 and gastric cancer: FGFR2 amplifications have been found in 10% of gastric cancers (50) and were also found in a subset of human TNBC patients (39, 51); FGFR2 amplifications are estimated to occur in ~4% of TNBC samples, resulting in constitutive activation of FGFR2 (52).